serine has been researched along with fluvoxamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sawamura, K; Someya, T; Suzuki, Y | 1 |
Asakura, M; Fujiwara, K; Haga, T; Kanai, S; Misonoo, A; Nakano, M; Ogawa, Y; Osada, K; Sasuga, Y; Takahashi, M; Tanaka, D; Yamaguchi, N; Yanagida, T | 1 |
2 other study(ies) available for serine and fluvoxamine
Article | Year |
---|---|
Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Chi-Square Distribution; Cytochrome P-450 CYP2D6; Depression; Female; Fluvoxamine; Humans; Japan; Male; Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Proline; Receptor, Serotonin, 5-HT2A; Serine; Tyrosine | 2006 |
Fluvoxamine and sigma-1 receptor agonists dehydroepiandrosterone (DHEA)-sulfate induces the Ser473-phosphorylation of Akt-1 in PC12 cells.
Topics: Animals; Cell Survival; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Fluvoxamine; Humans; PC12 Cells; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Receptors, sigma; Serine; Sigma-1 Receptor | 2010 |